The antidiuretic effect of small doses of adenosine triphosphate has been confirmed in both the rat and the rabbit after intravenous, intraperitoneal and intramuscular injection. This action of adenosine triphosphate, which closely resembles that of 'pitressin', was shared, to a lesser degree, by related compounds possessing either a —6NH2 or a —P2O7 group.
The effect could not be explained in terms of pre-renal deviation of water, either by failure of absorption, or by the formation of an exudate at the site of injection. Nor could it be explained by an alteration in renal haemodynamics, since the blood pressure and glomerular filtration rate were unaffected by the intraperitoneal doses used. Noxious afferent stimuli were also excluded as causative factors.
The antidiuretic action of adenosine triphosphate was inhibited by removal of the neurohypophysis and was accompanied by a fall in the antidiuretic hormone content of the posterior lobe of the pituitary.
The plasma and urine of the adenosine triphosphate-treated rats contained an antidiuretic substance which behaved like 'pitressin'.
In the rabbit, doses of adenosine triphosphate below the threshold for intravenous injection, caused marked changes in the rate of water excretion on intracarotid injection. The direction of the response depended on the state of hydration in the same way as the response to 'pitressin'.
The antidiuretic effect of small doses of adenosine triphosphate is thought to be due to the liberation of antidiuretic hormone from the posterior lobe of the pituitary. After large doses of adenosine triphosphate the cardiovascular and the other changes accompanying the state of shock will contribute to the effect.
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 2 | 0 | 0 |
| PDF Downloads | 2 | 1 | 0 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
